CA
Cormorant Asset Management, LP Other
US US · SEC (Form 4)
€76m
▲ Purchases (22 ops.)
Discover the full record of transactions filed by Cormorant Asset Management, LP. Officer active across 10 companies, notably Verve Therapeutics, Inc.. In total, 66 filings have been logged. Total volume traded: €76.7m. The latest transaction was filed on 12 May 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations 66 total
€135,518 6,387 shares @ €21.2178 50.0% of flow
Common Stock
SEC:0001231919-26-000495:0 · 12 May 2026
Ideal exit: 6 Feb 2027 (T+270) €135,518 6,387 shares @ €21.2178 100.0% of flow
Common Stock
SEC:0001231919-26-000495 · 12 May 2026
Ideal exit: 6 Feb 2027 (T+270) €2,291 302 shares @ €7.5859 0.0014% mcap 1.5% of flow
Common Stock
SEC:0001104659-22-073920:0 · 21 Jun 2022
Ideal exit: 18 Mar 2023 (T+270) €19m 9,480,052 shares @ €2.0385 0.61% mcap 100.0% of flow
Ordinary Shares
SEC:0001104659-22-072990:0 · 16 Jun 2022
Ideal exit: 13 Mar 2023 (T+270) €151,702 20,000 shares @ €7.5851 0.094% mcap 98.5% of flow
Common Stock
SEC:0001104659-22-071465:0 · 13 Jun 2022
Ideal exit: 10 Mar 2023 (T+270) 05,543 shares 0
Common Stock
SEC:0001104659-22-071026:0 · 10 Jun 2022
04,500 shares 0
Common Stock
SEC:0001104659-22-069745:0 · 8 Jun 2022
€340,696 1,005,686 shares @ €0.3388 2.20% mcap 30.9% of flow
Common Stock
SEC:0001104659-22-065351:0 · 26 May 2022
€760,622 1,250,000 shares @ €0.6085 4.91% mcap 69.1% of flow
Common Stock
SEC:0001104659-22-064706:0 · 23 May 2022
3,642,229 shares
Common Stock
SEC:0001104659-22-059645:0 · 10 May 2022
€31m 2,200,000 shares @ €14.093 16.41% mcap 100.0% of flow
Common Stock
SEC:0001104659-22-052318:0 · 26 Apr 2022
Ideal exit: 21 Jan 2023 (T+270) 1,699,998 shares
Common Stock
SEC:0001104659-22-041080:0 · 29 Mar 2022
€722,778 175,318 shares @ €4.1227 100.0% of flow
Common Stock
SEC:0001104659-22-040146:0 · 28 Mar 2022
Ideal exit: 23 Dec 2022 (T+270) €4m 342,143 shares @ €11.2929 0.88% mcap 32.1% of flow
Common Stock
SEC:0001104659-22-034568:0 · 14 Mar 2022
Ideal exit: 9 Dec 2022 (T+270) €478,750 40,154 shares @ €11.9229 0.11% mcap 4.0% of flow
Common Stock
SEC:0001104659-22-032990:0 · 9 Mar 2022
Ideal exit: 4 Dec 2022 (T+270) €747,485 63,662 shares @ €11.7415 0.17% mcap 6.2% of flow
Common Stock
SEC:0001104659-22-031596:0 · 4 Mar 2022
Ideal exit: 29 Nov 2022 (T+270) €101,449 8,746 shares @ €11.5994 0.023% mcap 0.8% of flow
Common Stock
SEC:0001104659-22-029417:0 · 28 Feb 2022
Ideal exit: 25 Nov 2022 (T+270) €3m 214,922 shares @ €11.8409 0.58% mcap 21.1% of flow
Common Stock
SEC:0001104659-22-027432:0 · 23 Feb 2022
Ideal exit: 20 Nov 2022 (T+270) €2m 166,229 shares @ €12.9952 0.49% mcap 17.9% of flow
Common Stock
SEC:0001104659-22-025736:0 · 17 Feb 2022
Ideal exit: 14 Nov 2022 (T+270) €2m 166,229 shares @ €12.9522 0.49% mcap 17.9% of flow
Common Stock
SEC:0001104659-22-024375:0 · 14 Feb 2022
Ideal exit: 11 Nov 2022 (T+270) 616,786 shares
Common Stock
SEC:0001567619-22-001163 · 11 Jan 2022
616,786 shares
Common Stock
SEC:0001567619-22-001163:0 · 11 Jan 2022
785,303 shares
Common Stock
SEC:0001567619-21-018789 · 25 Oct 2021
785,303 shares
Common Stock
SEC:0001567619-21-018789:0 · 25 Oct 2021
668,854 shares
Common Stock
SEC:0001567619-21-018355 · 13 Oct 2021
25 of 66 declarations
Load more (41 remaining) About Cormorant Asset Management, LP Cormorant Asset Management, LP is a significant shareholder of Verve Therapeutics, Inc.